Status:
COMPLETED
The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss
Lead Sponsor:
Hasselt University
Conditions:
Muscle Disuse
Neuromuscular Electrical Stimulation (NMES)
Eligibility:
MALE
18-80 years
Phase:
NA
Brief Summary
Subjects who are hospitalized in the ICU will be included after 24 hours of intubation during their ICU stay. Twice-daily Neuromuscular Electrical Stimulation (NMES) will be performed on one leg for 2...
Eligibility Criteria
Inclusion
- Male
- Age between 18 and 80 years
- Expected sedated time of \>24h
Exclusion
- Spinal Cord Injury
- Arterial operaties on the legs
- Local wounds that prohibit NMES
- Chronic use of corticosteroids
- Intake of certain antithrombotic drugs
- Presence of implantable cardioverter defibrillator and/or pacemaker
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01521637
Start Date
January 1 2012
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Belgium